May 1996
Volume 37, Issue 6
Free
Articles  |   May 1996
Endothelin-induced changes of second messengers in cultured human ciliary muscle cells.
Author Affiliations
  • S Matsumoto
    Department of Pharmacology, North Texas eye Research Institute, University of North Texas, Health Science Center at Fort Worth, USA.
  • T Yorio
    Department of Pharmacology, North Texas eye Research Institute, University of North Texas, Health Science Center at Fort Worth, USA.
  • P E Magnino
    Department of Pharmacology, North Texas eye Research Institute, University of North Texas, Health Science Center at Fort Worth, USA.
  • L DeSantis
    Department of Pharmacology, North Texas eye Research Institute, University of North Texas, Health Science Center at Fort Worth, USA.
  • I H Pang
    Department of Pharmacology, North Texas eye Research Institute, University of North Texas, Health Science Center at Fort Worth, USA.
Investigative Ophthalmology & Visual Science May 1996, Vol.37, 1058-1066. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S Matsumoto, T Yorio, P E Magnino, L DeSantis, I H Pang; Endothelin-induced changes of second messengers in cultured human ciliary muscle cells.. Invest. Ophthalmol. Vis. Sci. 1996;37(6):1058-1066.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

PURPOSE: To characterize the pharmacology of endothelin-induced changes in phospholipase C (PLC) activity, intracellular calcium concentration ([Ca2+]i) and cyclic adenosine monophosphate (cAMP) in cultured human ciliary muscle (HCM) cells. METHODS: Changes in PLC activity of HCM cells were determined by production of [3H] inositol phosphates. [Ca2+]i was determined by single-cell dynamic fluorescence ratio imaging. Radioimmunoassays were used to determine cAMP and prostaglandin E2 (PGE2) concentrations. RESULTS: Endothelin-1 (ET-1) stimulated PLC (mean EC50 = 335 pM) and activated calcium mobilization in HCM cells. These effects were mediated by the endothelin ETA receptor subtype because at ETB receptor-selective agonist, sarafotoxin S6c, was ineffective. Additionally, effects of ET-1 were inhibited by pretreatment with a selective ETA agonist, BQ610 (mean pKi = 9.96 for PLC). ET-1 also stimulated the production of PGE2 (mean EC50 = 12.0 nM) and cAMP (mean EC50 = 5.2 nM) by these cells. PGE2 appeared to mediate the stimulatory effect of ET-1 on adenylyl cyclase because blockade of ET-1-induced PGE2 production by 10 microM indomethacin also completely blocked the ET-1-activated cAMP production. CONCLUSIONS: ET-1 stimulated PLC and increased [Ca2+]i in HCM calls by the ETA receptor subtype. ET-1 also increased cAMP production, an effect likely mediated by the enhanced production of prostaglandins.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×